+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

HER2-positive Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2-positive Gastric Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
CD3 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD3 Antigen Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lung Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Lung Adenocarcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HPV-induced Cutaneous Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

HPV-induced Cutaneous Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Castleman Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Castleman Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cancer Therapy Related Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Therapy Related Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bevacizumab - Biosimilar Insight, 2025 - Product Thumbnail Image

Bevacizumab - Biosimilar Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2025 - Product Thumbnail Image

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
CAR-T - Pipeline Insight, 2025 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
ALK Positive Non-Small Cell Lung Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

ALK Positive Non-Small Cell Lung Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025 - Product Thumbnail Image

EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more